| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $271K | +13.6% | — |
| SG&A Expense | $231K | -31.8% | -88.5% |
| Operating Income | -$1.9M | +2.1% | +35.4% |
| Pre-tax Income | -$2.9M | +29.3% | +2.2% |
| Net Income | -$2.9M | +29.3% | +2.2% |
| EPS (Basic) | -$0.05 | +58.3% | +72.2% |
| EPS (Diluted) | -$0.05 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.3M | -13.4% | — |
| Accounts Receivable | $339K | — | — |
| Current Assets | $7.8M | -9.0% | +4926.7% |
| Total Assets | $10.1M | -7.1% | +308.8% |
| Current Liabilities | $93K | +47.5% | -90.5% |
| Total Liabilities | $146K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | — |
| Investing Cash Flow | -$123K | — | — |
| Financing Cash Flow | $11.9M | — | — |
| +58.3% |
| +72.2% |
| -25.3% |
| -85.5% |
| Stockholders' Equity | $9.9M | -6.8% | +579.7% |